FR2401167A1 - Derives de thienothiazine utiles comme medicaments - Google Patents

Derives de thienothiazine utiles comme medicaments

Info

Publication number
FR2401167A1
FR2401167A1 FR7824130A FR7824130A FR2401167A1 FR 2401167 A1 FR2401167 A1 FR 2401167A1 FR 7824130 A FR7824130 A FR 7824130A FR 7824130 A FR7824130 A FR 7824130A FR 2401167 A1 FR2401167 A1 FR 2401167A1
Authority
FR
France
Prior art keywords
medicinal products
derivatives useful
thienothiazine derivatives
thienothiazine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7824130A
Other languages
English (en)
Other versions
FR2401167B1 (fr
Inventor
Rudolf Pfister
Paul Zeller
Dieter Binder
Otto Hromatka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2401167A1 publication Critical patent/FR2401167A1/fr
Application granted granted Critical
Publication of FR2401167B1 publication Critical patent/FR2401167B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La présente invention concerne des dérivés de thiénothiazine. Ces dérivés ont pour formule :
FR7824130A 1977-08-22 1978-08-18 Derives de thienothiazine utiles comme medicaments Granted FR2401167A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU78009A LU78009A1 (de) 1977-08-22 1977-08-22 Verfahren zur herstellung von thiazinderivaten

Publications (2)

Publication Number Publication Date
FR2401167A1 true FR2401167A1 (fr) 1979-03-23
FR2401167B1 FR2401167B1 (fr) 1981-07-24

Family

ID=19728681

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7824130A Granted FR2401167A1 (fr) 1977-08-22 1978-08-18 Derives de thienothiazine utiles comme medicaments

Country Status (15)

Country Link
US (1) US4187303A (fr)
JP (1) JPS5448791A (fr)
AU (1) AU3891778A (fr)
BE (1) BE869866A (fr)
CH (1) CH640540A5 (fr)
DE (1) DE2835760A1 (fr)
DK (1) DK370278A (fr)
FR (1) FR2401167A1 (fr)
GB (1) GB2002771B (fr)
IL (1) IL55371A0 (fr)
IT (1) IT1098283B (fr)
LU (1) LU78009A1 (fr)
NL (1) NL7808672A (fr)
SE (1) SE7808819L (fr)
ZA (1) ZA784624B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
JPS61156673U (fr) * 1985-03-20 1986-09-29
MX174093B (es) * 1987-06-10 1994-04-21 Pfizer 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA
ATA39088A (de) 1988-02-18 1990-06-15 Binder Dieter Dr Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
AT399880B (de) * 1992-07-03 1995-08-25 Chem Pharm Forsch Gmbh Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
US5246050A (en) * 1992-07-10 1993-09-21 The Goodyear Tire & Rubber Company Tubeless shield and assembly
CA2567223A1 (fr) * 2004-05-19 2005-11-24 Boehringer Ingelheim International Gmbh Procede pour traiter des maladies et des etats associes a un niveau modifie de peptides beta amyloides et nouveaux composes d'enolcarboxamide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2016455A1 (fr) * 1968-08-27 1970-05-08 Pfizer
FR2282893A1 (fr) * 1974-08-26 1976-03-26 Hoffmann La Roche Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1308533A (en) 1969-06-02 1973-02-21 Pfizer Benzothiazine dioxides as anti-thombotic agents
US3646021A (en) * 1970-07-16 1972-02-29 Warner Lambert Pharmaceutical 4 - hydroxy - 3 - furylcarbamyl - 2h - 1 2-benzothiazine 1 1-dioxides and process thereof
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3808205A (en) * 1971-09-10 1974-04-30 Warner Lambert Co Process for the preparation of 4-hydroxy-3-carbamyl-2h-1,2-benzothiazine 1,1-dioxides and 4-hydroxy-3(2h)-1,2-benzothiazine carboxylate-1,1-dioxides
US3714155A (en) * 1971-09-27 1973-01-30 Warner Lambert Co 4-hydroxy-2,n-dimethyl-2h-1,2-benzothiazine-3-carboxanilide1,1-dioxide and process therefor
US3821211A (en) * 1972-03-10 1974-06-28 Warner Lambert Co Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolycarbamoyl)-2-methyl-2h-1,2-benzothiazine 1,1-dioxide
CA1066711A (fr) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Derives de thiophene
DE2534689B2 (de) 1974-09-16 1979-03-01 Basf Ag, 6700 Ludwigshafen 23-Dihydro-3-oxo-thieno-isothiazol-1,1-dioxide
MC1135A1 (fr) 1976-02-23 1977-11-18 Hoffmann La Roche Derives de thiazine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2016455A1 (fr) * 1968-08-27 1970-05-08 Pfizer
FR2282893A1 (fr) * 1974-08-26 1976-03-26 Hoffmann La Roche Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation

Also Published As

Publication number Publication date
AU3891778A (en) 1980-02-21
JPS5448791A (en) 1979-04-17
GB2002771B (en) 1982-05-26
CH640540A5 (de) 1984-01-13
DE2835760A1 (de) 1979-03-08
US4187303A (en) 1980-02-05
LU78009A1 (de) 1979-05-23
GB2002771A (en) 1979-02-28
IL55371A0 (en) 1978-10-31
IT7826894A0 (it) 1978-08-21
SE7808819L (sv) 1979-02-23
JPS6130676B2 (fr) 1986-07-15
DK370278A (da) 1979-02-23
NL7808672A (nl) 1979-02-26
BE869866A (fr) 1979-02-21
ZA784624B (en) 1979-08-29
IT1098283B (it) 1985-09-07
FR2401167B1 (fr) 1981-07-24

Similar Documents

Publication Publication Date Title
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
FR2403340A1 (fr) Derives imidazoliques utiles comme medicaments
FR2370051A1 (fr) Nouveaux benzamides substitues utilisables comme medicaments
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
FR2361353A1 (fr) Derives de cyclohexane utiles comme cristaux liquides
FR2381763A1 (fr) Dibenzo(b-e) (diazepines-1,4) et leur utilisation comme antischizophreniques
FR2361889A1 (fr) Nouveaux derives de 1-(benzazolyalcoyl)piperidine
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2359830A1 (fr) 6-alcoyl-pyrimidines utilisables comme medicament, notamment contre la malaria
FR2359144A1 (fr) Sels de l'acide clavulanique utilisable comme medicaments
FR2389629A1 (fr)
FR2370028A1 (fr) Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
FR2387955A1 (fr) Derives de l'aniline utilisables comme medicament
FR2361340A1 (fr) Nouvelles anilines substituees utilisables comme medicament
FR2386521A1 (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
FR2445328A1 (fr) Derives du 14-oxo-e-homo-eburnane, leur procede de preparation et leur utilisation comme medicament
FR2361326A1 (fr) Derives de cyclohexane utiles comme agents odoriferants
FR2391179A1 (fr) Nouveaux composes utiles comme intermediaires de synthese de la vitamine e
FR2401167A1 (fr) Derives de thienothiazine utiles comme medicaments
FR2361366A1 (fr) Derives heterocycliques de la guanidine
FR2383950A1 (fr) Penicillines utilisables comme medicament
FR2443457A1 (fr) Derives de 1-phenyl-2-amino-1-propanol, leur procede de preparation et leur utilisation comme medicaments
FR2384770A1 (fr) Nouveaux derives de quinazoline utiles comme medicaments
FR2377997A1 (fr) Aralcoylanilines utilisables comme medicament

Legal Events

Date Code Title Description
ST Notification of lapse